The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...

While Alzheimer’s disease is the most common type of dementia, there’s another variation that is also relatively prevalent. Lewy body dementia (LBD) affects more than 1 million people in the US. It is ...

In Dementia Action Week (19 - 25 May 2025), Jacqui Cannon, CEO of the Wigan-based Lewy Body Society, said: “The Government and the NHS must prioritise dementia. It is a shocking truth that one in ...

In the RewinD-LB extension study, neflamapimod reduced plasma glial fibrillary acidic protein (GFAP) levels, which correlated ...

It’s the second most common type of dementia, after Alzheimer’s, yet many remain unfamiliar with its challenges. “The most common disease that people have never heard of.” That’s how 73-year-old Don ...

Studies headed by researchers at Johns Hopkins Medicine have uncovered a possible molecular connection between air pollution and an increased risk of developing Lewy body dementia (LBD). The team ...

A team of researchers found there is a possible molecular connection between air pollution and an increased risk of developing Lewy body dementia. The study builds on a decade of research linking ...

We know inhaling polluted air harms our lungs—but what about our brains? According to compelling new research, pollution may put you at higher risk of being hospitalized for one of the most common ...